Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Aspen Pharma

This page shows the latest Aspen Pharma news and features for those working in and with pharma, biotech and healthcare.

Aspen to pay millions to NHS following drug pricing investigation

Aspen to pay millions to NHS following drug pricing investigation

South African pharma company Aspen is set to pay the NHS £8m ($9.9m) in the next few weeks, after an investigation by the UK’s Competition and Markets Authority (CMA) ... This acquisition made Aspen the sole owner of all existing fludrocortisone

Latest news

  • Italian pharma scandals prompts call for EU-wide pricing probe Italian pharma scandals prompts call for EU-wide pricing probe

    Aspen fined 5.2m for threat to halt supply of cancer drugs if price hikes not accepted. ... The case against Aspen's Italian subsidiary was first launched in 2014, which according to consumer group Altroconsumo "disappeared from the market after Aspen

  • GSK sells another chunk of South Africa's Aspen GSK sells another chunk of South Africa's Aspen

    In the same year, Aspen also took control of a GSK generic drugs unit in Australia and bought one of the UK-based company's manufacturing facilities in France. ... We continue to believe in the strategy of Aspen and we remain committed to working

  • GSK sells off anticoagulants for £700m GSK sells off anticoagulants for £700m

    pharma company The Aspen Group. ... In Indonesia, GSK will distribute and market the brands under licence from Aspen.

  • Sigma to sell pharma division to Aspen

    Australian Sigma Pharmaceuticals has agreed to sell its drugs unit to Aspen, Africa's largest drug maker, for A$900m (£513m/$801m). ... The Board has concluded that Aspen's proposal to acquire the pharmaceuticals division is the best alternative for

  • Aspen and Pfizer Australia face lawsuits

    Two pharma firms in Australia face a class action lawsuit following alleged links between Parkinson's treatments and addictive behaviour. ... result of taking Parkinson's treatments Cabaser (cabergoline), made by Pfizer, and Permax (pergolide mesylate),

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • A new EU in the making, what lies ahead for pharma? A new EU in the making, what lies ahead for pharma?

    And the Greens are not really the greatest supporters of the pharma industry…. ... She has been creative in the way she pushed the boundaries of the treaties with, for example, the pricing investigation over Aspen Pharma.

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    For an indepth analysis of these deals, read'Pharma deals during October 2014'. ... 130. TesoRx Pharma/Aspen. Licence [C]. For TSX 002 an unmodified oral  testosterone replacement.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...

Quick links